Atherogenic dyslipidaemia is generally observed in MS patients.13-17 A combination of elevated serum triglycerides and apolipoprotein B, together with reduced HDL levels, and increased VLDL (very low-density lipoprotein) values is typically reported.12 Dyslipidaemia is associated with coronary heart disease and progression of target end-organ damage, and its levels increase with lower socio-economic status in developing countries.18 This evidence concerns the gene APOB and coronary artery disorder.